OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mitragynine (Kratom) impairs spatial learning and hippocampal synaptic transmission in rats
Zurina Hassan, Farah Wahida Suhaimi, Surash Ramanathan, et al.
Journal of Psychopharmacology (2019) Vol. 33, Iss. 7, pp. 908-918
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Kratom—Pharmacology, Clinical Implications, and Outlook: A Comprehensive Review
Steven Eastlack, Elyse M. Cornett, Alan D. Kaye
Pain and Therapy (2020) Vol. 9, Iss. 1, pp. 55-69
Open Access | Times Cited: 138

Mitragynine Attenuates Morphine Withdrawal Effects in Rats—A Comparison With Methadone and Buprenorphine
Rahimah Hassan, Pike-See Cheah, Sreenivasan Sasidharan, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 61

Kratom Abuse Potential 2021: An Updated Eight Factor Analysis
Jack E. Henningfield, Daniel W. Wang, Marilyn A. Huestis
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 26

Kratom instrumentalization for severe pain self-treatment resulting in addiction – A case report of acute and chronic subjective effects
Elisabeth Müller, Thomas Hillemacher, Christian P. Müller
Heliyon (2020) Vol. 6, Iss. 7, pp. e04507-e04507
Open Access | Times Cited: 33

A systematic review of (pre)clinical studies on the therapeutic potential and safety profile of kratom in humans
Elisabeth Prevete, Kim P. C. Kuypers, Eef L. Theunissen, et al.
Human Psychopharmacology Clinical and Experimental (2021) Vol. 37, Iss. 1
Open Access | Times Cited: 32

Mitragynine (Kratom)—Withdrawal behaviour and cognitive impairments can be ameliorated by an epigenetic mechanism
Suleiman Yunusa, Christian P. Müller, Zurina Hassan
British Journal of Pharmacology (2024) Vol. 181, Iss. 13, pp. 2070-2084
Closed Access | Times Cited: 4

Modulatory effects of Kratom extract on the gut microbiota of rats: implications for health
Nattaya Thongsepee, Sumet Amonyingcharoen, Pholasit Chamod, et al.
BMC Complementary Medicine and Therapies (2025) Vol. 25, Iss. 1
Open Access

Comparative Brain Proteome Analysis of an Indole Alkaloid of Kratom, Mitragynine and Kratom Juice in Rats
Sohaib Jumaah Owaid, Suleiman Yunusa, Lay‐Harn Gam, et al.
(2025)
Closed Access

Comparative metabolomics analysis reveals alkaloid repertoires in young and mature Mitragyna speciosa (Korth.) Havil. Leaves
Rubashiny Veeramohan, Arief Izzairy Zamani, Kamalrul Azlan Azizan, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0283147-e0283147
Open Access | Times Cited: 9

Formation of multiple ion types during MALDI imaging mass spectrometry analysis of Mitragyna speciosa alkaloids in dosed rat brain tissue
Zhongling Liang, Yingchan Guo, Nicholas R. Ellin, et al.
Talanta (2024) Vol. 274, pp. 125923-125923
Closed Access | Times Cited: 3

Pharmacology of Herbal Sexual Enhancers: A Review of Psychiatric and Neurological Adverse Effects
Pietro Brunetti, Alfredo Fabrizio Lo Faro, Anastasio Tini, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 10, pp. 309-309
Open Access | Times Cited: 27

The IntelliCage System: A Review of Its Utility as a Novel Behavioral Platform for a Rodent Model of Substance Use Disorder
Nurul Iman Ismail, Nurul Aiman Mohd Yusof, Ummi Nasrah Talib, et al.
Frontiers in Behavioral Neuroscience (2021) Vol. 15
Open Access | Times Cited: 22

Xanthone-enriched fraction ofGarcinia mangostanaand α-mangostin improve the spatial learning and memory of chronic cerebral hypoperfusion rats
Ning Tiang, Mohamad Anuar Ahad, Vikneswaran Murugaiyah, et al.
Journal of Pharmacy and Pharmacology (2020) Vol. 72, Iss. 11, pp. 1629-1644
Closed Access | Times Cited: 22

Kratom use for depression/anxiety self-management: challenges during the COVID-19 pandemic – A case report
Elisabeth Müller, Thomas Hillemacher, Christian P. Müller
Heliyon (2021) Vol. 7, Iss. 5, pp. e07039-e07039
Open Access | Times Cited: 16

The role of AMPA and NMDA receptors in mitragynine effects on hippocampal synaptic plasticity
Mohamad Azmeer Effendy, Suleiman Yunusa, Noorul Hamizah Mat, et al.
Behavioural Brain Research (2022) Vol. 438, pp. 114169-114169
Closed Access | Times Cited: 12

The effects of chronic mitragynine (Kratom) exposure on the EEG in rats
Farah Wahida Suhaimi, Zurina Hassan, Sharif Mahsufi Mansor, et al.
Neuroscience Letters (2021) Vol. 745, pp. 135632-135632
Closed Access | Times Cited: 15

Kratom withdrawal: Discussions and conclusions of a scientific expert forum
Jack E. Henningfield, Marek C. Chawarski, Albert Garcia‐Romeu, et al.
Drug and Alcohol Dependence Reports (2023) Vol. 7, pp. 100142-100142
Open Access | Times Cited: 6

Bio-enhanced fraction from Clitoria ternatea root extract ameliorates cognitive functions and in vivo hippocampal neuroplasticity in chronic cerebral hypoperfusion rat model
Mohamad Anuar Ahad, Nelson Jeng‐Yeou Chear, Lim Gin Keat, et al.
Ageing Research Reviews (2023) Vol. 89, pp. 101990-101990
Closed Access | Times Cited: 6

Mitragynine (Kratom)-Induced Cognitive Impairments in Mice Resemble Δ9-THC and Morphine Effects: Reversal by Cannabinoid CB1 Receptor Antagonism
Nurul Iman Ismail, Nur Aimi Zawami Ahmad, Nurul Aiman Mohd Yusof, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 14

Adolescent kratom exposure affects cognitive behaviours and brain metabolite profiles in Sprague-Dawley rats
Aiman Nadhirah Zul Aznal, Nurul Aqmar Mohamad Nor Hazalin, Zurina Hassan, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 9

Methadone, Buprenorphine, and Clonidine Attenuate Mitragynine Withdrawal in Rats
Rahimah Hassan, Sreenivasan Sasidharan, Christian P. Müller, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 12

Mitragynine improves cognitive performance in morphine-withdrawn rats
Chiek Yi You, Zurina Hassan, Christian P. Müller, et al.
Psychopharmacology (2021) Vol. 239, Iss. 1, pp. 313-325
Closed Access | Times Cited: 12

Mechanism of psychoactive substance-induced cognitive disorders: does tau protein play a role?
Yuye Wang, JiaCheng Lv, Jining He, et al.
Frontiers in Bioscience-Landmark (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 8

Beneficial and Adverse Health Effects of Kratom (Mitragyna speciosa): A Critical Review of the Literature
J. Thomas Heywood, S. Smallets, Dennis J. Paustenbach
Food and Chemical Toxicology (2024) Vol. 192, pp. 114913-114913
Closed Access | Times Cited: 1

Page 1 - Next Page

Scroll to top